SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Procter&Gamble Healt - Quaterly Results

01 Aug 2025 Evaluate
The June 2025 quarter revenue stood at Rs. 3387.40 millions, up 19.33% as compared to Rs. 2838.80 millions during the corresponding quarter last year.The Net Profit of the company vaulted to 294.40% to Rs. 661.80  millions from Rs. 167.80 millions in the previous quarter.OP of the company witnessed a marginal growth to 943.70 millions from 503.80 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202406 202306 % Var
Sales 3387.40 2838.80 19.33 12729.10 11512.60 10.57 11512.60 12296.20 -6.37
Other Income 40.30 21.30 89.20 143.80 156.30 -8.00 156.30 183.90 -15.01
PBIDT 943.70 503.80 87.32 4231.10 3216.30 31.55 3216.30 3430.70 -6.25
Interest 1.20 2.00 -40.00 5.50 7.20 -23.61 7.20 7.70 -6.49
PBDT 942.50 299.90 214.27 4225.60 3007.20 40.52 3007.20 3423.00 -12.15
Depreciation 54.40 71.60 -24.02 221.30 274.00 -19.23 274.00 281.00 -2.49
PBT 888.10 228.30 289.01 4004.30 2733.20 46.51 2733.20 3142.00 -13.01
TAX 226.30 60.50 274.05 998.40 723.40 38.01 723.40 847.30 -14.62
Deferred Tax -3.10 -67.40 -95.40 -8.00 -86.00 -90.70 -86.00 -50.60 69.96
PAT 661.80 167.80 294.40 3005.90 2009.80 49.56 2009.80 2294.70 -12.42
Equity 166.00 166.00 0.00 166.00 166.00 0.00 166.00 166.00 0.00
PBIDTM(%) 27.86 17.75 56.98 33.24 27.94 18.98 27.94 27.90 0.13

Procter&Gamble Healt Share Price

5164.50 -30.05 (-0.58%)
04-May-2026 12:13 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1819.30
Dr. Reddys Lab 1301.75
Cipla 1330.85
Zydus Lifesciences 901.55
Lupin 2350.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×